BioEleSonic™ is a developer of innovative medical devices, with a technology platform based on Precisely Modulated Acoustic Energy (PMAE). BioEleSonic’s most advanced medical device, BES-1001 specializes in the treatment of nasal congestion and related pain; a condition estimated to affect over 20% of the global population.

As the first drug-free, non-invasive and connected portable treatment of this condition, this clinical-stage medical device is a major innovation in its field with strategic objectives to partner for further development and licensing.  

BioEleSonic™ is a developer of innovative medical devices, with a technology platform based on Precisely Modulated Acoustic Energy (PMAE). BioEleSonic’s most advanced medical device, BES-1001 specializes in the treatment of nasal congestion and related pain; a condition estimated to affect over 20% of the global population.

As the first drug-free, non-invasive and connected portable treatment of this condition, this clinical-stage medical device is a major innovation in its field with strategic objectives to partner for further development and licensing.

How BioEleSonic delivers impact

Addressing unmet medical needs in high-prevalence and rare disorders

Accelerating access to affective, non-invasive and drug-free treatments

Providing access to affordable healthcare through at-home use

UN Sustainable Development Goals

Key partnerships